G1 Therapeutics, Inc. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2019 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 0.39 | 7,000 | 2,730 | 90,444 | |
| Jan 28 2019 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 0.39 | 7,000 | 2,730 | 21,700 | 14.7 K to 21.7 K (+47.62 %) |
| Jan 28 2019 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 0.39 | 7,000 | 2,730 | 90,444 | |
| Jan 28 2019 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 0.39 | 7,000 | 2,730 | 21,700 | 14.7 K to 21.7 K (+47.62 %) |
| Jan 17 2019 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance | Option Exercise | M | 3.72 | 2,000 | 7,440 | 8,333 | |
| Jan 17 2019 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance | Buy | M | 3.72 | 2,000 | 7,440 | 6,000 | 4 K to 6 K (+50.00 %) |
| Jan 17 2019 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 9,000 | 3,510 | 380,286 | |
| Jan 17 2019 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 9,000 | 3,510 | 28,000 | 19 K to 28 K (+47.37 %) |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | M | 0.30 | 13,333 | 4,000 | 0 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | M | 0.30 | 10,336 | 3,101 | 0 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | M | 0.30 | 15,816 | 4,745 | 0 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | M | 0.39 | 27,000 | 10,530 | 0 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | M | 0.39 | 13,333 | 5,200 | 0 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | A | 19.56 | 15,000 | 293,400 | 15,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Buy | M | 0.39 | 40,333 | 15,730 | 129,237 | 88.9 K to 129.2 K (+45.37 %) |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Buy | M | 0.30 | 39,485 | 11,846 | 88,904 | 49.4 K to 88.9 K (+79.90 %) |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance | Option Exercise | A | 19.56 | 20,000 | 391,200 | 20,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Hanson James S. | General Counsel | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | Chief Operating Off ... | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | DEMAREE JOHN | Chief Commercial Of ... | Option Exercise | A | 19.56 | 60,000 | 1,173,600 | 60,000 | |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | A | 19.56 | 225,000 | 4,401,000 | 225,000 |